- Home
- ANNX vs BCML Comparison
ANNX vs BCML Comparison
Compare ANNX & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- BCML
- Stock Information
- Founded
- ANNX 2011
- BCML 2004
- Country
- ANNX United States
- BCML United States
- Employees
- ANNX N/A
- BCML N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- BCML Major Banks
- Sector
- ANNX Health Care
- BCML Finance
- Exchange
- ANNX Nasdaq
- BCML Nasdaq
- Market Cap
- ANNX 263.3M
- BCML 301.0M
- IPO Year
- ANNX 2020
- BCML N/A
- Fundamental
- Price
- ANNX $2.42
- BCML $26.74
- Analyst Decision
- ANNX Strong Buy
- BCML Strong Buy
- Analyst Count
- ANNX 4
- BCML 1
- Target Price
- ANNX $12.50
- BCML $32.00
- AVG Volume (30 Days)
- ANNX 1.7M
- BCML 18.3K
- Earning Date
- ANNX 08-11-2025
- BCML 07-17-2025
- Dividend Yield
- ANNX N/A
- BCML 2.92%
- EPS Growth
- ANNX N/A
- BCML 2.85
- EPS
- ANNX N/A
- BCML 2.18
- Revenue
- ANNX N/A
- BCML $96,577,000.00
- Revenue This Year
- ANNX N/A
- BCML $3.00
- Revenue Next Year
- ANNX N/A
- BCML $7.27
- P/E Ratio
- ANNX N/A
- BCML $12.55
- Revenue Growth
- ANNX N/A
- BCML N/A
- 52 Week Low
- ANNX $1.29
- BCML $20.25
- 52 Week High
- ANNX $7.85
- BCML $30.13
- Technical
- Relative Strength Index (RSI)
- ANNX 47.32
- BCML 44.66
- Support Level
- ANNX $2.29
- BCML $26.31
- Resistance Level
- ANNX $2.62
- BCML $27.41
- Average True Range (ATR)
- ANNX 0.17
- BCML 0.79
- MACD
- ANNX -0.01
- BCML -0.11
- Stochastic Oscillator
- ANNX 37.74
- BCML 20.06
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.